Baghdadi et al. discovered that in patients with advanced NSCLC, IL-34, by its interaction with CSF-1R, facilitates the M2-TAM polarization, which is significantly associated with tumor immunosuppression and tumor growth (107). Here, IL34 is linked to non-small cell lung carcinoma.